Anixa Biosciences Inc.

NASDAQ: ANIX · Real-Time Price · USD
2.97
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
2.97
0.00%
After-hours: Aug 15, 2025, 07:56 PM EDT

Anixa Biosciences Cash Flow Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021
Net Income
-12.22M -12.54M -12.58M -12.39M -11.66M -10.83M -9.93M -10.74M -10.96M -12.25M -13.77M -14.31M -15.93M -14.77M -13.13M -11.3M -9.49M -9.71M
Depreciation & Amortization
-222K -219K 37K 40K 48K 48K 46K 45K 44K 43K 42K 46.94K 52.1K 55.74K 59.86K 57.49K 88.96K 88.97K
Stock-Based Compensation
4.07M 4.34M 4.42M 4.6M 4.66M 4.57M 4.42M 3.79M 4.08M 4.6M 6M 8.31M 10.06M 9.43M 8.06M 6.19M 4.04M 4.1M
Other Working Capital
-284K -312K 110K -1M -524K -777K -901K 380K 190K -47K 356K -75.91K 71.73K 337.03K 174.72K -118.32K -172.14K -202.1K
Other Non-Cash Items
391K 1.41M 1.54M 1.54M 1.42M 221K 92K 747K 738K 777K 2.71M 2.66M 6.05M 7.1M 5.14M 7.45M 4.21M 2.88M
Deferred Income Tax
n/a n/a -37K -37K -37K -37K n/a n/a n/a n/a n/a -633.59K -633.59K -633.59K -633.59K -2.95M -2.95M -2.95M
Change in Working Capital
3K 315K 526K -935K -453K -644K -1.06M 147K 194K -541K 485K -56.44K -274.08K 329.41K 78.55K -249.89K 95.09K -57.38K
Operating Cash Flow
-7.98M -7.93M -7.33M -8.38M -7.18M -6.53M -6.21M -5.83M -5.78M -7.28M -6.49M -5.94M -6.03M -4.96M -4.94M -5.31M -5.12M -5.43M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -159.67K -159.67K -159.67K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.23M 5.23M 5.23M
Purchase of Investments
-40.96M -43.75M -63.77M -64.22M -61.74M -56.6M -44.41M -38.83M -35.64M -26.82M -22.49M -17.26M -10.35M -19M -16.5M -9.9M -12.79M -4.14M
Sales Maturities Of Investments
62.6M 63.6M 68.05M 67.03M 60.85M 51.71M 38.81M 23.9M 18.79M 13.66M 11.76M 19.25M 16.25M 16.25M 12.54M 2.42M 3.79M 3.79M
Other Investing Acitivies
-13M -13M 129K -464K -1.44M -4.89M -5.6M -14.93M -16.86M -13.16M -10.73M -804.53K 3.11M -5.54M -7.36M -11.21M -12.73M -4.08M
Investing Cash Flow
8.64M 6.85M 4.28M 2.82M -888K -4.89M -5.6M -14.93M -16.86M -13.16M -10.73M 2M 5.91M -2.74M -3.92M -6.22M -7.74M 905.45K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-33K -33K -33K n/a n/a n/a n/a -384K -384K -384K -384K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
277K 337K 421K 559K 413K 430K 366K -297K 529K 455K 452K 836K 7K -353 103.47K 106.47K 106.47K 106.82K
Financial Cash Flow
256K 1.14M 3.42M 3.59M 3.44M 2.63M 366K -297K 529K 455K 452K 979.62K 150.62K 25.5M 31.57M 32.83M 37.68M 13.69M
Net Cash Flow
915K 55K 356K -1.97M -4.63M -8.79M -11.45M -21.06M -22.11M -19.99M -16.77M -2.97M 28.86K 17.8M 22.71M 21.29M 24.82M 9.16M
Free Cash Flow
-7.98M -7.93M -7.33M -8.38M -7.18M -6.53M -6.21M -5.83M -5.78M -7.28M -6.49M -5.94M -6.03M -4.96M -4.94M -5.47M -5.28M -5.59M